How to set up B2B pricing strategy: step-by-step tutorial for healthcare and life sciences in the APAC region

This edition of the Growth Broker playbook is written for commercial leaders at healthtech, medtech, and life-sciences companies operating in the APAC region. In this market, APAC buyers span very different cultures and reward vendors who adapt playbooks per market, so the way you install B2B pricing strategy has to be shaped to that reality from day one.

This is the exact sequence we use to install B2B pricing strategy when a client says "we want this live by Monday". B2B pricing strategy is the deliberate choice of unit, level, and packaging that maximises expansion revenue, and everything below is designed so a single operator can run it end to end.

Step one: write down the account list. If you cannot name 200 companies, you do not yet have a target — you have a demographic. Refine until every account passes a "would we take their money?" gut check.

Step two: define the trigger. What has to be true in the world for you to touch this account this week? For B2B pricing strategy, that trigger connects directly to net revenue retention.

Inside healthcare and life sciences, the binding constraint is almost always regulated-sale cycle length, not intent, and in the APAC region it is compounded by the fact that market-by-market adaptation, not one-size playbooks is what actually gates growth. B2B pricing strategy is only useful here when it is pointed at both constraints at once.

Steps three to five: pick the tools, wire the data, and dry-run against ten accounts. Do not scale until a human has read every artefact and would send it themselves.

Steps six and seven: go live at 20% of intended volume for one week. Track net revenue retention daily, not weekly. Kill anything that misses the bar.

Steps eight to ten: ramp to full volume, publish a Friday review, and set the next 30-day target. Do not chase new tools until the current setup has run for a full month.

The most common tutorial failure is matching a competitor instead of pricing to value — usually in step six, when volume feels safe and copy quality slips. Guard step six with a checklist and a second pair of eyes.

Concretely for healthcare and life sciences in the APAC region: the healthcare teams that install this get past procurement instead of dying in it, and the APAC teams that install this stop treating the region as one market and start winning it as many. That is the reason it is worth installing B2B pricing strategy deliberately for this market rather than importing a playbook designed for somewhere else.